Anouk A. Leijs
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Structural insights into MERS and SARS coronavirus membrane proteins.
Journal: Communications biology
Published: April 07, 2025
Epi-Cyclophellitol Cyclosulfate, a Mechanism-Based Endoplasmic Reticulum α-Glucosidase II Inhibitor, Blocks Replication of SARS-CoV-2 and Other Coronaviruses.
Journal: ACS central science
Published: March 28, 2024
A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein.
Journal: Nature
Published: February 21, 2024
Characterization of SARS-CoV-2 replication in human H1299/ACE2 cells: A versatile and practical infection model for antiviral research and beyond.
Journal: Antiviral research
Published: January 23, 2024
Deubiquitinating activity of SARS-CoV-2 papain-like protease does not influence virus replication or innate immune responses in vivo.
Journal: PLoS pathogens
Published: January 19, 2024
SARS-CoV-2-infected human airway epithelial cell cultures uniquely lack interferon and immediate early gene responses caused by other coronaviruses.
Journal: Clinical & translational immunology
Published: September 08, 2023
Multiantigen pan-sarbecovirus DNA vaccines generate protective T cell immune responses.
Journal: JCI insight
Published: May 23, 2023
Honokiol Inhibits SARS-CoV-2 Replication in Cell Culture at a Post-Entry Step.
Journal: Microbiology spectrum
Published: May 22, 2023
R-Propranolol Has Broad-Spectrum Anti-Coronavirus Activity and Suppresses Factors Involved in Pathogenic Angiogenesis.
Journal: International journal of molecular sciences
Published: January 10, 2023
Showing 1-10 of 10
Last Updated: 09/26/2026